In ₹ Crore except Per Share Latest Annual	HEALTHX FY26	SURAKSHA FY26	KRSNAA FY26	NEPHROPLUS FY26	Peer Average
Valuation — at last close
P/E	754.59×	51.71×	◆ 15.91×	74.12×	47.25× +1497%
P/B	◆ 1.39×	6.80×	1.65×	5.65×	4.70× -71%
EV/EBITDA	◆ -19.27×	17.17×	8.44×	26.26×	17.29× -211%
Market Cap	₹888 Cr	₹1,664 Cr	₹1,615 Cr	₹6,307 Cr	₹3,195 Cr -72%
Growth
Revenue CAGR 3Y	8.26%	—	◆ 16.63%	—	16.63% -50%
Revenue CAGR 5Y	19.20%	—	—	—	—
Net Income CAGR 3Y	—	—	17.76%	—	17.76%
Revenue YoY (latest Q)	◆ 49.73%	20.75%	22.05%	—	21.40% +132%
Net Income YoY (latest Q)	-92.53%	◆ 40.00%	-19.34%	—	10.33% -996%
Profitability
EBITDA Margin	-3.95%	◆ 30.73%	27.42%	22.72%	26.96% -115%
Net Income Margin	-0.11%	10.12%	◆ 13.13%	7.69%	10.31% -101%
Return on Common Equity	0.18%	◆ 14.11%	10.89%	6.88%	10.63% -98%
Return on Capital Employed	—	◆ 15.88%	9.62%	11.63%	12.38%
Return on Assets	-0.15%	◆ 8.04%	6.53%	5.22%	6.60% -102%
Credit & Quality
Total Debt/Equity	0.03×	◆ 0.01×	0.55×	0.07×	0.21× -86%
Interest Coverage	-75.12×	◆ 4.30×	3.53×	2.26×	3.36× -2333%
Scale — latest FY
Revenue / Total Income	₹1,319 Cr	₹310 Cr	₹773 Cr	₹999 Cr	₹694 Cr +90%
Net Income	−₹1.4 Cr	₹31.4 Cr	₹101 Cr	₹76.8 Cr	₹69.9 Cr -102%
Total Assets	₹936 Cr	₹448 Cr	₹1,824 Cr	₹1,471 Cr	₹1,248 Cr -25%
EPS	₹0.37	₹6.18	₹31.3	₹8.48	₹15.32 -98%
Book Value per Share	₹201.47	₹47.01	₹302.23	₹111.27	₹153.5 +31%

◆ best value in the comp set per metric · Δ = subject vs average of the other companies.

« ‹ › »Latest: FY26 · ConsolidatedFA Financial Analysis · alphave

Data & compliance. Descriptive financial information from official NSE/BSE filings — for information and education only, not investment advice, a recommendation, or a valuation. Standalone = parent entity; consolidated includes subsidiaries. Historical multiples pair each fiscal year's filed figures with that FY-end market close; the Current column uses the last close with the latest filed annuals. Figures are cross-verified via accounting identities and NSE×BSE agreement — XBRL cross-verified ✓ 95%.